These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14106733)

  • 1. FURTHER STUDIES ON THE INHIBITION AND STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYMES OF RAT LIVER BY VARIOUS COMPOUNDS.
    KATO R; CHIESARA E; VASSANELLI P
    Biochem Pharmacol; 1964 Jan; 13():69-83. PubMed ID: 14106733
    [No Abstract]   [Full Text] [Related]  

  • 2. VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.
    KATO R; VASSANELLI P; FRONTINO G; CHIESARA E
    Biochem Pharmacol; 1964 Jul; 13():1037-51. PubMed ID: 14201126
    [No Abstract]   [Full Text] [Related]  

  • 3. [VARIATIONS IN THE ENZYME ACTIVITY AND PHARMACOLOGIC EFFECTS IN RELATION TO AGE].
    TRABUCCHI E; CHIESARA E
    G Gerontol Suppl; 1964; 23():SUPPL 32:71-99. PubMed ID: 14185934
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of some microsomal drug-metabolizing enzymes by inhibitors of cholesterol biosynthesis.
    KATO R; VASSANELLI P; CHIESARA E
    Biochem Pharmacol; 1963 Apr; 12():349-51. PubMed ID: 13958397
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of drug metabolism in the mouse by a hypocholesterolemic agent, AY-9944.
    Marton AV; Chappel CI
    Experientia; 1964 Sep; 20(9):517-8. PubMed ID: 5856346
    [No Abstract]   [Full Text] [Related]  

  • 6. STRESS-DRUG INTERACTIONS: EVIDENCE FOR RAPID ENZYME INDUCTION.
    DRIEVER CW; BOUSQUET WF
    Life Sci (1962); 1965 Aug; 4():1449-54. PubMed ID: 14320949
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased activities of liver microsomal drug-metabolizing enzymes in the rats bearing Walker carcinosarcoma.
    KATO R; FRONTINO G; VASSANELLIP
    Experientia; 1963 Jan; 19():31-2. PubMed ID: 13958401
    [No Abstract]   [Full Text] [Related]  

  • 8. METABOLIC FACTORS DETERMINING A HIGHER RESISTANCE TO STRYCHNINE IN GUINEA PIGS.
    KATO R; VASSANELLI P; FRONTINO G
    Arch Int Pharmacodyn Ther; 1963 Aug; 144():416-22. PubMed ID: 14060864
    [No Abstract]   [Full Text] [Related]  

  • 9. IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY.
    BURNS JJ
    Am J Med; 1964 Sep; 37():327-31. PubMed ID: 14218162
    [No Abstract]   [Full Text] [Related]  

  • 10. ENDOCRINE MODIFICATION OF DRUG RESPONSES IN THE RAT.
    BOUSQUET WF; RUPE BD; MIYA TS
    J Pharmacol Exp Ther; 1965 Mar; 147():376-9. PubMed ID: 14269613
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES OF POTENTIATION OF HEXOBARBITONE INFUSED INTRAVENOUSLY.
    MCCANCE I
    Arch Int Pharmacodyn Ther; 1964 Mar; 148():270-86. PubMed ID: 14171755
    [No Abstract]   [Full Text] [Related]  

  • 12. MORPHINE INHIBITION OF DRUG METABOLISM IN THE RAT.
    BOUSQUET WF; RUPE BD; MIYA TS
    Biochem Pharmacol; 1964 Jan; 13():123-5. PubMed ID: 14104925
    [No Abstract]   [Full Text] [Related]  

  • 13. STRESS MODIFICATION OF DRUG RESPONSE.
    RUPE BD; BOUSQUET WF; MIYA TS
    Science; 1963 Sep; 141(3586):1186-7. PubMed ID: 14043362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INHIBITION OF HEXOBARBITAL METABOLISM BY ETHYLMORPHINE AND CODEINE IN THE INTACT RAT.
    RUBIN A; TEPHYL TR; MANNERING GJ
    Biochem Pharmacol; 1964 Jul; 13():1053-7. PubMed ID: 14201127
    [No Abstract]   [Full Text] [Related]  

  • 15. CONDITIONED SUPPRESSION IN RATS AND THE EFFECT OF PHARMACOLOGICAL AGENTS THEREON.
    LAUENER H
    Psychopharmacologia; 1963 Jul; 4():311-25. PubMed ID: 14048553
    [No Abstract]   [Full Text] [Related]  

  • 16. [ELECTROPHYSIOLOGICAL RESEARCH ON THE CHANGES IN THE STRYCHNINE POINTS INDUCED BY TREATMENT WITH PSYCHOTROPIC AND ANTICONVULSIVE DRUGS].
    ARRIGO A; SAVOLDI F; TARTARA A
    Riv Neurol; 1964; 34():311-9. PubMed ID: 14208874
    [No Abstract]   [Full Text] [Related]  

  • 17. [DIFFERENCES IN MICROSOMAL OXIDATION AND ACETYLATION OF DRUGS IN DIFFERENT SPECIES AND RACES].
    SIEGERT M; ALSLEBEN B; LIEBENSCHUETZ W; REMMER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Jul; 247():509-21. PubMed ID: 14254451
    [No Abstract]   [Full Text] [Related]  

  • 18. [BIOCHEMICAL AND ULTRASTRUCTURAL CHANGES CAUSED BY VARIOUS TREATMENTS AT THE HEPATIC LEVEL].
    CHIESARA E; CLEMENTI F; CONTI F
    Tijdschr Gastroenterol; 1964; 7():190-9. PubMed ID: 14264624
    [No Abstract]   [Full Text] [Related]  

  • 19. APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES.
    BURNS JJ; CUCINELL SA; KOSTER R; CONNEY AH
    Ann N Y Acad Sci; 1965 Mar; 123():273-86. PubMed ID: 14329210
    [No Abstract]   [Full Text] [Related]  

  • 20. THE PLACE OF ACETYLSALICYLIC ACID IN PSYCHOPHARMACOLOGY. AN EXPERIMENTAL STUDY.
    FROMMEL E; FLEURY C; LEDEBUR IV; BEGUIN M; FAMILY S
    Arzneimittelforschung; 1963 Oct; 13():851-6. PubMed ID: 14196759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.